تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
الصفحة الرئيسية
المساعدة والأسئلة الشائعة
English
עברית
العربية
الصفحة الرئيسية
الملفات الشخصية
الوحدات البحثية
نتاج البحث
الجوائز
أنشطة
البحث حسب الخبرة أو الاسم أو الانتماء
عرض الملف الشخصي الخاص بـ Scopus
שי אשכנזי
Prof.
Dean
,
Adelson School of Medicine
Full Professor
,
Department of Medicine
Dean
,
Department of Medicine
الانتماء السابق
Dean
,
Department of Medicine
https://orcid.org/0000-0001-7244-0679
1982 …
2024
نتاج الأبحاث سنويًا
معاينة
بصمة
الشبكة
نتاج البحث
(382)
ملفات شخصية مماثلة
(6)
بصمة
تأتي تسميات الموضوعات هذه من أعمال هذا الشخص. فهما يشكلان معًا بصمة فريدة.
فرز حسب
الوزن
أبجديًا
Keyphrases
Israel
100%
Shigella
67%
Shigellosis
41%
Vaccination
32%
Shigella Sonnei
31%
Shiga Toxin
28%
Pediatric
27%
Lipopolysaccharide
26%
Escherichia Coli
25%
Israeli
24%
Shigella Flexneri
22%
Hospitalization
20%
COVID-19
20%
Bacteremia
20%
Hepatitis A
19%
Fever
18%
Immunogenicity
17%
Infections in children
16%
Young children
16%
Urinary Tract Infection
16%
Odds Ratio
16%
Seizure
16%
Attention Deficit Hyperactivity Disorder
15%
Conjugate Vaccine
14%
Confidence Interval
14%
Healthcare Workers
14%
Neonate
13%
O-polysaccharide
13%
Serious Bacterial Infection
13%
Medical Center
13%
Shigella Flexneri 2a
12%
Antimicrobial Resistance
12%
Hospitalized children
12%
C-reactive Protein
12%
Antibiotics
12%
Rotavirus Gastroenteritis
12%
Shigella Dysenteriae
12%
Hepatitis A Virus
11%
Pediatricians
11%
Risk Factors
11%
Enterohemorrhagic Escherichia Coli
11%
Infective Endocarditis
11%
Febrile Infant
10%
Acute Gastroenteritis
10%
Gastroenteritis
10%
Bacterial Infection
10%
Convulsion
10%
Tumor Necrosis Factor-α
10%
Pediatric Patients
9%
Nitric Oxide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Shigella
59%
Infection
51%
Shigellosis
39%
Lipopolysaccharide
28%
Diseases
28%
Escherichia coli
28%
Shigella flexneri
23%
Bloodstream Infection
21%
Shigella sonnei
19%
Antimicrobial Resistance
19%
Conjugate Vaccine
18%
Immunogenicity
17%
Shiga Toxin
17%
Urinary Tract Infection
16%
Bacterial Infection
16%
Polysaccharide
15%
Gastroenteritis
15%
Antibiotics
15%
Infectious Agent
12%
Shigella dysenteriae
12%
Immunoglobulin G
11%
Prospective Study
11%
Rotavirus
11%
Bronchiolitis
10%
Hepatitis A
10%
Prevalence
10%
Cytotoxin
10%
Tumor Necrosis Factor
10%
Immunoglobulin A
10%
Penicillin
9%
Streptococcus Pneumonia
9%
C Reactive Protein
9%
SARS Coronavirus
8%
Hepatitis A Vaccine
8%
Diarrhea
8%
Verotoxin 1
8%
Placebo
8%
Human Respiratory Syncytial Virus
8%
Neurologic Disease
8%
Hepatitis A Virus
7%
Cotrimoxazole
7%
Salmonella
7%
Shigella Vaccine
7%
Coagulase Negative Staphylococcus
7%
Clinical Trial
7%
Attention Deficit Disorder
7%
Enzyme-Linked Immunosorbent Assay
7%
Staphylococcal Bacteremia
7%
Antiinfective Agent
7%
Prematurity
7%
Medicine and Dentistry
Pediatrics
46%
Infection
30%
Shigella
25%
Bacillary Dysentery
22%
COVID-19
15%
Odds Ratio
14%
Epileptic Seizure
14%
Diseases
14%
Urinary Tract Infection
13%
Bloodstream Infection
12%
Attention Deficit Disorder
12%
Pediatrician
12%
Toddlers
12%
Tumor Necrosis Factor
11%
Bronchiolitis
10%
Pediatrics Patient
10%
Gastroenteritis
10%
Bacterial Infection
9%
Escherichia coli
9%
C Reactive Protein
9%
Neonate
9%
Infectious Disease
8%
Prevalence
8%
Diagnosis
8%
Neurologic Disease
8%
Antibiotics
8%
Shigella dysenteriae
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Heart Surgery
7%
Influenza Vaccination
7%
Rotavirus
7%
Prospective Study
6%
Infective Endocarditis
6%
Diarrhea
6%
Medicine
6%
Acute Gastroenteritis
6%
Influenza Vaccine
6%
Human Respiratory Syncytial Virus
6%
Hepatitis A
6%
Serotype
6%
Neisseria meningitidis
6%
Antibiotic Therapy
6%
Antibiotic Resistance
5%
Case-Control Study
5%
Antibiogram
5%
Cross Sectional Study
5%
Virus Infection
5%
Health Care
5%
Coagulase Negative Staphylococcus
5%
Health Care Cost
5%